Detalhe da pesquisa
1.
PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.
Circ Cardiovasc Genet
; 8(2): 356-62, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25583995
2.
Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.
Circ Cardiovasc Genet
; 7(2): 144-50, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24563418
3.
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
J Am Coll Cardiol
; 62(21): 1966-1976, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23916927
4.
Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.
PLoS One
; 7(7): e41139, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22879865
5.
Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.
J Am Coll Cardiol
; 63(9): 943, 2014 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315920